These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4732200)

  • 1. [Research and experience with fenfluramine in obesity].
    Pawan GS
    Vie Med Can Fr; 1973 May; 2(5):415-22. PubMed ID: 4732200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology and biochemistry of fenfluramine].
    Duhault J
    Vie Med Can Fr; 1973; 2(2):141-7. PubMed ID: 4574870
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of obesity.
    Court JM
    Drugs; 1972; 4(5):411-8. PubMed ID: 4568066
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation in a patient being treated with fenfluramine plus phentermine for simple obesity.
    Rothman RB
    J Clin Psychiatry; 1996 Feb; 57(2):92-3. PubMed ID: 8591979
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological effects of 780SE (992) on hyperlipidaemic and obese rats.
    Duhault J; Boulander M; Beregi L
    Postgrad Med J; 1975; 51 Suppl 1():99-104. PubMed ID: 1219688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Insulin secretion and hydrocarbon tolerance in essential obesity in women (influence of fenfluramine, phenformin and D-amphetamine)].
    Cabezas Cerrato J; Catalán E; Vila T; Fernández-Cruz A
    Rev Clin Esp; 1973 May; 129(4):337-42. PubMed ID: 4720279
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of obesity with fenfluramine (Ponderal)].
    Persson I; Andersen UD; Deckert T
    Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the behavior of some plasma lipid fractions (nonesterified fatty acids, triglycerides and total cholesterol) in obese subjects].
    Balestreri R; Marcenaro A; Barreca T
    Arch Maragliano Patol Clin; 1972; 28(1):101-10. PubMed ID: 4679283
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative trial of fenfluramine and diethylpropion inbesity.
    Silverstone JT; Cooper RM; Begg RR
    Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
    [No Abstract]   [Full Text] [Related]  

  • 11. New agent for obesity management.
    Clemenson ND
    J Fam Pract; 1996 Sep; 43(3):224; author reply 225. PubMed ID: 8797741
    [No Abstract]   [Full Text] [Related]  

  • 12. Appetite suppressants for obesity.
    Budenholzer B
    J Fam Pract; 1997 Jan; 44(1):19-20. PubMed ID: 9010359
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.
    Follows OJ
    Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronotherapy of obesity. II. Variations in eating behavior in the obese after fenfluramine treatment in relation to time of administration].
    Di Vincenzo M; Guagnano MT; Della Loggia F; Sensi S
    Boll Soc Ital Biol Sper; 1982 Jun; 58(12):740-4. PubMed ID: 7104097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of phentermine and diethylpropion in the treatment of obese patients in general practice.
    Vallé-Jones JC; Brodie NH; O'Hara H; O'Hara J; McGhie RL
    Pharmatherapeutica; 1983; 3(5):300-4. PubMed ID: 6844367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Desopimon in the treatment of obesity].
    Balabanski L; Tashev T; Meretev A; Babulkov Kh
    Vutr Boles; 1976 Dec; 15(6):42-5. PubMed ID: 1014625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of obesity. Appetite suppressant drugs and intestinal by-pass surgery.
    Bleehen SS; Edwards IR; Clark RG
    Br J Dermatol; 1976 Aug; 95(2):219-222. PubMed ID: 782507
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacologic management of obesity.
    Cerda JJ
    J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term weight control study: conclusions.
    Weintraub M
    Clin Pharmacol Ther; 1992 May; 51(5):642-6. PubMed ID: 1587079
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of phenethylbiguanide on body weight and some serum lipid indices in obese subjects, obese diabetics and obese subjects with potential diabetes].
    Pompei A; Marcenaro A; Foppiani E; Jacopino GE
    Clin Ter; 1969 Dec; 51(6):541-60. PubMed ID: 5371379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.